Sort
261,768 grants matching “gene therapy”
Clinical Proteomics and Laser Capture Microdissection
$1,018,608Elaine S Jaffe · Basic Sciences · Z01 · FY2007 · CA
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
$1,018,572Norah A. Terrault · University Of California, San Francisco · U01 · FY2017 · DK
Precision microRNA medicine in cancer
$1,018,331Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA
MULTICENTER CAREER DEVELOPMENT PROGRAM FOR PHYSICAL AND OCCUPATIONAL THERAPY
$1,018,312Michael J Mueller · Washington University · K12 · FY2013 · HD
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$1,018,271Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2015 · ES
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$1,018,170Martin Akerman · Envisagenics, Inc. · R44 · FY2022 · CA
IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT
$1,018,168Frederick Gerard Moeller · University Of Texas Hlth Sci Ctr Houston · P50 · FY2009 · DA
Activating Cell Death Pathways in Breast Cancer Cells
$1,018,140Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes
$1,017,950Timothy E Sweeney · Inflammatix, Inc. · R44 · FY2022 · GM
Molecular Tracer and Imaging Core Facility
$1,017,566Dale O Kiesewetter · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2020 · EB
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$1,017,518Anthony Bernard Schryvers · University Of Calgary · R01 · FY2024 · AI
Understanding the Role of the Host Response in HIVSIV Infection
$1,017,478Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development of Transplant Strategies Uniquely Responsive to the Needs of Children
$1,017,454Allan D. Kirk · Emory University · U01 · FY2012 · AI
Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease
$1,017,452Jeffrey Stavenhagen · Therini Bio, Inc. · U01 · FY2022 · AG
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,017,359Carmelo J Rizzo · Vanderbilt University · P01 · FY2014 · CA
DNA Replication, Cancer and Chemotherapy
$1,017,335Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Epigenetic mechanisms regulating the Igf2/H19 and Kcnq1 locus
$1,017,315Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia
$1,017,232Laurel Omert · New Health Sciences, Inc. · R44 · FY2025 · HL
Modifiers of elastin arteriopathy
$1,017,049Beth Kozel · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Genome instability in cancer: telomeres and DNA repair
$1,017,000Titia De Lange · Rockefeller University · R35 · FY2020 · CA
Phosphoinositides and Cancer Metabolism
$1,017,000Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R35 · FY2016 · CA
Phosphoinositides and Cancer Metabolism
$1,017,000Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · CA
Phosphoinositides and Cancer Metabolism
$1,017,000Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R35 · FY2017 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$1,017,000Mark Reid Philips · New York University School Of Medicine · R35 · FY2021 · CA
Genome instability in cancer: telomeres and DNA repair
$1,017,000Titia De Lange · Rockefeller University · R35 · FY2017 · CA